The analysis of human papillomavirus DNA in penile cancer tissue by in situ hybridization.
暂无分享,去创建一个
M. Yao | Takeshi Sasaki | H. Uemura | T. Kawahara | Y. Yumura | D. Takamoto | J. Kasuga
[1] K. Stratton,et al. A Contemporary Review of HPV and Penile Cancer. , 2016, Oncology.
[2] E. Pirog. Immunohistochemistry and in situ hybridization for the diagnosis and classification of squamous lesions of the anogenital region. , 2015, Seminars in diagnostic pathology.
[3] G. Guimarães,et al. Prognostic factors in patients with penile carcinoma and inguinal lymph node metastasis , 2015, International journal of urology : official journal of the Japanese Urological Association.
[4] R. Melotti,et al. Recurrence and progression in patients with non‐muscle invasive bladder cancer: Prognostic models including multicolor fluorescence in situ hybridization molecular grading , 2014, International journal of urology : official journal of the Japanese Urological Association.
[5] C. Cohen,et al. Automated In Situ Hybridization For Human Papilloma Virus , 2014, Applied immunohistochemistry & molecular morphology (Print).
[6] C. Logie,et al. HPV vaccine acceptability among men: a systematic review and meta-analysis , 2013, Sexually Transmitted Infections.
[7] G. Sonpavde,et al. Penile cancer: current therapy and future directions. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] A. Freeman,et al. Genital lichen sclerosus/balanitis xerotica obliterans in men with penile carcinoma: a critical analysis , 2013, BJU international.
[9] Matthew Hickman,et al. Inequalities in the uptake of Human Papillomavirus Vaccination: a systematic review and meta-analysis , 2013, International journal of epidemiology.
[10] P. Delvenne,et al. Human papillomavirus, lichen sclerosus and penile cancer: a study in Belgium. , 2012, Vaccine.
[11] J. Dillner,et al. Penile cancer: epidemiology, pathogenesis and prevention , 2009, World Journal of Urology.
[12] A. Giuliano,et al. Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: a prospective study. , 2009, The Journal of infectious diseases.
[13] A. Giuliano,et al. The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study. , 2007, The Journal of infectious diseases.
[14] A. Giuliano,et al. Human Papillomavirus Prevalence and Type Distribution in Male Anogenital Sites and Semen , 2007, Cancer Epidemiology Biomarkers & Prevention.
[15] M. Senba,et al. The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand , 2006, Journal of medical virology.
[16] J. Berkhof,et al. Presence of high‐risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival , 2006, International journal of cancer.
[17] F. Barea,et al. Infection with human papillomaviruses of sexual partners of women having cervical intraepithelial neoplasia. , 2006, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[18] F. Smedts,et al. HPV in situ hybridization: Impact of different protocols on the detection of integrated HPV , 2005, International journal of cancer.
[19] K. Horiguchi,et al. Expression profiling of mouse placental lactogen II and its correlative genes using a cDNA microarray analysis in the developmental mouse placenta. , 2003, The Journal of reproduction and development.
[20] P. Fuchs,et al. Human papillomavirus-positive tonsillar carcinomas: a different tumor entity? , 2003, Medical Microbiology and Immunology.
[21] L. Turek,et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx , 2003, International journal of cancer.
[22] F. X. Bosch,et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.
[23] A. Lopes,et al. Human papillomavirus as a prognostic factor in carcinoma of the penis , 2001, Cancer.
[24] D. Sidransky,et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.
[25] H. van Tinteren,et al. Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: detection and prognostic significance. , 1994, Gynecologic oncology.
[26] M. Furihata,et al. High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. , 1993, Cancer research.
[27] P. Humphrey,et al. Prevalence of human papillomavirus types 16 and 18 in squamous‐cell carcinoma of the penis: A retrospective analysis of primary and metastatic lesions by differential polymerase chain reaction , 1992, International journal of cancer.
[28] F. Abdul-Karim,et al. Detection and localization of human papillomavirus in penile condylomas and squamous cell carcinomas using in situ hybridization with biotinylated DNA viral probes. , 1989, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[29] B. Rose,et al. Short Communication Absence of Human Papillomavirus in Tonsillar Squamous Cell Carcinomas from Chinese Patients , 2003 .
[30] F. Smedts,et al. Relationship between human papillomavirus type 16 in the cervix and intraepithelial neoplasia. , 1999, Obstetrics and gynecology.
[31] F. X. Bosch,et al. Human papillomavirus and other risk factors for cervical cancer. , 1997, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[32] K. Fujinaga,et al. Detection of human papillomavirus deoxyribonucleic acid in penile carcinoma by polymerase chain reaction and in situ hybridization. , 1993, The Journal of urology.